Epigenomic Profiling of Human CD4+ T Cells Supports a Linear Differentiation Model and Highlights Molecular Regulators of Memory Development  by Durek, Pawel et al.
ResourceEpigenomic Profiling of Human CD4+ T Cells
Supports a Linear Differentiation Model and
Highlights Molecular Regulators of Memory
DevelopmentGraphical AbstractHighlightsd Comprehensive epigenomes for human CD4+ T memory
subsets generated and analyzed
d Integrative analyses support a linear model of memory T cell
differentiation
d Epigenetic control of transcriptional regulators of memory
differentiation revealed
d Chromatin changes highlight novel regulators for T memory
cell differentiationDurek et al., 2016, Immunity 45, 1148–1161
November 15, 2016 ª 2016 Elsevier Inc.
http://dx.doi.org/10.1016/j.immuni.2016.10.022Authors
Pawel Durek, Karl Nordstro¨m,
Gilles Gasparoni, ..., Jo¨rn Walter,
Alf Hamann, Julia K. Polansky
Correspondence
julia.polansky@drfz.de
In Brief
As part of the IHEC consortium, Durek
et al. (2016) generated deep epigenomes
and transcriptomes of CD4+ memory
T cell subsets to infer their lineage
relationships and to demonstrate the
impact of epigenetic regulation on known
and novel molecular regulators involved
in memory generation. Explore the Cell
Press IHEC webportal at www.cell.com/
consortium/IHEC.
Immunity
ResourceEpigenomic Profiling of Human CD4+ T Cells Supports
a Linear Differentiation Model and Highlights
Molecular Regulators of Memory Development
Pawel Durek,1,23 Karl Nordstro¨m,2,23 Gilles Gasparoni,2,23 Abdulrahman Salhab,2,23 Christopher Kressler,1,23
Melanie de Almeida,1,23 Kevin Bassler,3 Thomas Ulas,3 Florian Schmidt,4,5 Jieyi Xiong,6 Petar Glazar,7
Filippos Klironomos,7 Anupam Sinha,8 Sarah Kinkley,9 Xinyi Yang,9 Laura Arrigoni,10 Azim Dehghani Amirabad,4,5
Fatemeh Behjati Ardakani,4,5 Lars Feuerbach,11 Oliver Gorka,12 Peter Ebert,4 Fabian M€uller,4 Na Li,9 Stefan Frischbutter,1
Stephan Schlickeiser,13 Carla Cendon,14 Sebastian Fro¨hler,6 B€arbel Felder,15 Nina Gasparoni,2 Charles D. Imbusch,11
Barbara Hutter,11 Gideon Zipprich,15 Yvonne Tauchmann,16 Simon Reinke,17 Georgi Wassilew,18 Ute Hoffmann,1
Andreas S. Richter,10 Lina Sieverling,11 DEEP Consortium,19 Hyun-Dong Chang,14 Uta Syrbe,20 Ulrich Kalus,16
J€urgen Eils,15 Benedikt Brors,11 Thomas Manke,10 J€urgen Ruland,12,21,22 Thomas Lengauer,4 Nikolaus Rajewsky,7
Wei Chen,6 Jun Dong,14 Birgit Sawitzki,13 Ho-Ryun Chung,9 Philip Rosenstiel,8 Marcel H. Schulz,4,5 Joachim L. Schultze,3
Andreas Radbruch,14 Jo¨rn Walter,2 Alf Hamann,1 and Julia K. Polansky1,24,*
1Experimental Rheumatology, German Rheumatism Research Centre, 10117 Berlin, Germany
2Department of Genetics, University of Saarland, 66123 Saarbr€ucken, Germany
3Life and Medical Sciences Institute, Genomics and Immunoregulation, University of Bonn, 53115 Bonn, Germany
4Department of Computational Biology and Applied Algorithmics, Max Planck Institute for Informatics, 66123 Saarbr€ucken, Germany
5Excellence Cluster on Multimodal Computing and Interaction, Saarland University, 66123 Saarbr€ucken, Germany
6Berlin Institute for Medical Systems Biology, Max-Delbr€uck Center for Molecular Medicine, 13125 Berlin, Germany
7Systems Biology of Gene Regulatory Elements, Max-Delbr€uck Center for Molecular Medicine, 13125 Berlin, Germany
8Institute of Clinical Molecular Biology, Christian-Albrechts-University, 24105 Kiel, Germany
9Otto Warburg Laboratories: Epigenomics at Max Plank Institute for Molecular Genetics, 14195 Berlin, Germany
10Max Planck Institute of Immunobiology and Epigenetics, 78108 Freiburg, Germany
11Applied Bioinformatics, Deutsches Krebsforschungszentrum, 59120 Heidelberg, Germany
12Institute for Clinical Chemistry and Pathobiochemistry, Klinikum rechts der Isar, Technical University 81675 Munich, Germany
13Institute of Medical Immunology, Charite´ University Medicine, 13353 Berlin, Germany
14Cell Biology, German Rheumatism Research Centre, 10117 Berlin, Germany
15Data Management and Genomics IT, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany
16Institut f€ur Transfusionsmedizin, Charite´ University Medicine, 12203 Berlin, Germany
17Berlin-Brandenburg Center for Regenerative Therapies, 13353 Berlin, Germany
18Center for Musculoskeletal Surgery, Charite´ University Medicine, 10117 Berlin, Germany
19http://www.deutsches-epigenom-programm.de/
20Medizinische Klinik f€ur Gastroenterologie, Infektiologie und Rheumatologie, Charite´ University Medicine, 12000 Berlin, Germany
21German Cancer Consortium (DKTK), 59120 Heidelberg, Germany
22German Center for Infection Research (DZIF), partner site 81675 Munich, Germany
23Co-first authors
24Lead Contact
*Correspondence: julia.polansky@drfz.de
http://dx.doi.org/10.1016/j.immuni.2016.10.022SUMMARY
The impact of epigenetics on the differentiation of
memory T (Tmem) cells is poorly defined. We gener-
ated deep epigenomes comprising genome-wide
profiles of DNA methylation, histone modifications,
DNA accessibility, and coding and non-coding RNA
expression in naive, central-, effector-, and terminally
differentiated CD45RA+ CD4+ Tmem cells from blood
and CD69+ Tmem cells from bone marrow (BM-
Tmem). We observed a progressive and prolifera-
tion-associated global loss of DNA methylation in
heterochromatic parts of the genome during Tmem
cell differentiation. Furthermore, distinct gradually
changing signatures in the epigenome and the tran-1148 Immunity 45, 1148–1161, November 15, 2016 ª 2016 Elsevier Iscriptome supported a linearmodel ofmemory devel-
opment in circulating T cells, while tissue-resident
BM-Tmembranched off with a unique epigenetic pro-
file. Integrative analyses identified candidate master
regulators of Tmem cell differentiation, including the
transcription factor FOXP1. This study highlights the
importance of epigenomic changes for Tmem cell
biology and demonstrates the value of epigenetic
data for the identification of lineage regulators.
INTRODUCTION
CD4+ T helper (Th) cells orchestrate the quality and quantity of
an adaptive immune reaction and contribute to immunity bync.
generating a pool of long-livedmemory (Tmem) cells, which arise
from naive T (Tn) cells after activation by primary antigen
encounter. Tmem cells are per se resting, almost non-dividing
cells, which can be subdivided into subpopulations based on
marker expression, tissue localization and functional properties.
Central memory (Tcm) cells appear most similar to Tn cells with
respect to their ability to recirculate through blood and lymphoid
tissues, the limited effector cytokine commitment, and their high
proliferative capacity (Sallusto et al., 1999). In contrast, T effector
memory (Tem) cells preferentially home to peripheral tissues and
show commitment for the selective production of effector cyto-
kine panels (e.g., IFN-g, IL-4, and IL-17) characteristic of their
functional subtype (Th1, Th2, and Th17, respectively). Their ca-
pacity to expand and differentiate is more limited than that of
Tcm cells—a feature also found for the so far poorly character-
ized CD4+ terminally differentiated CD45RA+ memory (Temra)
cells (Henson et al., 2012), which feature expression of selected
markers of Tn cells (e.g., CD45RA). In addition to these popula-
tions circulating through the blood, recent studies have high-
lighted the importance of tissue-resident memory cells (Carbone
et al., 2013; Schenkel and Masopust, 2014). CD4+ Tmem cells
from the bone marrow (BM-Tmem) have been shown to consti-
tute a major part of long-term memory in mouse and man
(Okhrimenko et al., 2014; Tokoyoda et al., 2009).
The developmental relationship of Tmem cell subsets is not
well defined. The question whether different Tmem subtypes
represent stages in a sequential linear differentiation process,
or whether they branch into different sublineages from early acti-
vation stages is still a subject of controversy (Ahmed et al., 2009;
Flossdorf et al., 2015; Harrington et al., 2008; Kaech and Cui,
2012). Similarly, master regulators controlling the transit from
naive to memory stages, particularly in the human system, are
largely unknown, partially due to the lack of suitable experi-
mental systems.
Epigenetic mechanisms play a key role in cell differentiation
by controlling expression programs that are stable over time
and through cellular generations and hence are prime candi-
dates for the imprinting of stable, heritable expression profiles.
Because Tmem cells do not revert to the naive stage, their
cellular program seems to be permanently switched, pointing
toward epigenetic regulation. Main players in epigenetic regu-
lation are DNA methylation (DNA-meth), histone modifications,
and non-coding RNAs, which together direct the rearrange-
ment of the chromatin to promote or to prevent expression
of the affected genes. Genome-wide analysis of such epige-
netic marks therefore allows for conclusions not only on the
current gene expression status but also facilitates insights
into the history and the future potential of cells. To date only
a few studies on mouse Tmem cells have been published, re-
porting limited datasets (Crompton et al., 2016; Hashimoto
et al., 2013; Komori et al., 2015; Russ et al., 2014). A deep
and systematic genome-wide analysis of the epigenetic land-
scape during human CD4+ Tmem cell differentiation is
currently lacking.
As part of the International Human Epigenome Consortium
(IHEC) and the German Epigenome Programme (DEEP), we
generated comprehensive epigenomic maps of ex vivo isolated
isogenic human CD4+ Tn cells and several Tmem cell subsets
from the blood and the bone marrow to address the questionof whether and how the epigenome contributes to the formation,
maintenance, and function of Tmem cell populations in humans.
Our data support a model of linear differentiation for circulating
human Tmem cells—a topic so far studied only in the murine
system. In addition, we find that many known molecular regula-
tors of Tmem cells are under epigenetic control and that epige-
netic changes point to novel regulator candidates, which are
likely to be involved in Tmem cell differentiation.
RESULTS
Generation of Genome-Wide Epigenetic Datasets of
Human CD4+ Tn Cells and Tmem Cell Subsets
To generate comprehensive epigenomic datasets (i.e., class I
epigenomes according to the IHEC standards) for the key
differentiation stages of human CD4+ Th cells, we sorted
CD4+ Tn, Tcm, Tem, and Temra cells from the peripheral blood
of healthy human donors by flow cytometry (Figure S1A). To
obtain sufficient cell numbers for the subsequent analyses
and to mitigate potential inter-donor variations, we used
pooled samples of 3–10 female donors (Table S1). For Tn,
Tcm, and Tem, analyses of all epigenetic parameters within
one replicate were carried out in parallel, i.e., were derived
from the same genetic donor pool and therefore represent
isogenic samples. For each sample we determined (1)
genome-wide DNA-meth profiles, by whole-genome bisulfite
sequencing (WBGS) or by reduced representation bisulfite
sequencing (RRBS), (2) DNA accessibility maps by nucleo-
some occupancy and methylome sequencing (NOMe-seq),
(3) high-resolution histone modification maps (by Chromatin
Immune-Precipitation sequencing, ChIP-seq) for H3K4me1
( = mono-methylation of lysine 4 on histone 3), H3K4me3,
H3K9me3, H3K27ac, H3K27me3, and H3K36me3 and, (4)
transcriptomes for total RNA (depleted from ribosomal
RNAs), messenger RNAs (mRNAs), long non-coding RNAs
(lncRNAs), micro RNAs (miRNA), and circular RNAs (circRNA)
by deep sequencing of three different RNA libraries (polyade-
nylated RNAs, small RNAs, and total RNAs depleted from
ribosomal RNAs). A selection of these datasets (Figure S1B)
was generated for CD4+ BM-Tmem cells, which were se-
parated into the CD69+ tissue-resident and the circulating
CD69 subsets (Figure S1A).
Progressive Segmented Loss of DNA-Meth Correlates
with Tmem Cell Differentiation
We profiled the DNA-meth landscape in Tn, Tcm, Tem, and
Temra cells using WGBS and observed a strong progressive
loss of DNA-meth in the order Tn-Tcm-Tem-Temra with mean
methylation levels for the entire genome dropping from 84% in
Tn to 67% in Temra (Figure 1A). Loss of methylation predomi-
nantly occurred in large domains of up to several hundreds of ki-
lobases (kb), which were decorated with the repressive histone
marks H3K27me3 and H3K9me3 (Figure 1B and Figure S2A).
Such regions are referred to as ‘‘partially methylated domains,
PMDs’’ and can be identified using established software pack-
ages (‘‘MethylSeekR,’’ Burger et al., 2013). PMDs contrasted
with broad regions that were uniformly fully methylated (‘‘fully
methylated regions,’’ FMRs, by MethylSeekR) and to peaks of
strong consistent de-methylation typically found in CpG islandsImmunity 45, 1148–1161, November 15, 2016 1149
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Figure 1. Global Loss of DNA-Meth in
Tmem Cells Occurs in Large Heterochro-
matic Regions
(A) Circle plots of WGBS data (Tn, Tcm, Tem of
donor pool Hf03, and Temra, Hf05) are shown.
Mean methylation levels in 10 Mb blocks are
depicted as color-coded (white-blue) bars. Heat-
maps (blue-red) indicate the methylation differ-
ence between the adjacent subsets. Total mean
methylation for each cell type is given in the center.
(B) Exemplary genomic view of Tn, Tcm, Tem
(Hf03 samples), and Temra (Hf05), displaying ex-
amples of the genomic segments called by the
MethylSeekR software from WGBS data (indi-
cated with boxes): PMD, partially methylated
domain; FMR, fully methylated region; LMR, low
methylated region; UMR, unmethylated region.
The following tracks are shown (top to bottom,
each for Tn, Tcm, Tem, Temra): Genes annotated
in RefSeq; MethylSeekR-segments; DNA-meth
(WGBS); 6 indicated histone modifications;
total RNA.
(C) Weighted average DNA-meth across the
MethylSeekR segments.
(D) Weighted average methylation across PMDs in
B cells (data from the BLUEPRINT project, see
Accession codes in Experimental Procedures).
Bnai, naive B cells (ERX625136); Bgc, geminal
center B cells (ERX715129); BmemCS, class-
switched memory B cells (ERX625127); Bpc,
plasma cells (ERX301127).
(E) PCA of DNA-meth data (based on WGBS).
CpGs with min. coverage = 5 were considered;
only CpGs with calls in all indicated samples
were used.(‘‘unmethylated regions,’’ UMRs) and transcriptional control re-
gions (e.g., CpG-low promoters and enhancers, ‘‘lowmethylated
regions,’’ LMRs). PMDs showed the strongest loss of methyl-
ation of all MethylSeekR segments (Figure 1C) and covered up
to 67% of the genome (in Tem cells; Figure S2B). Hence,
PMDs were responsible for the bulk of the observed global
DNA de-methylation in Tmem cell populations. PMD-associated
genes generally showed low expression levels compared to
FMR-associated genes and were fewer in number (Figure S2C).1150 Immunity 45, 1148–1161, November 15, 2016We observed a similar segmented loss
of global DNA-meth when re-examining
DNA-meth profiles from B cells pub-
lished by the BLUEPRINT consortium
(Kulis et al., 2015). Here too, PMDs
were the genomic segments that dis-
played progressive loss of DNA-meth
with differentiation into memory B cells
and antibody-secreting plasma cells
(Figure 1D), indicating that this phenom-
enon is shared during lymphocyte
development.
In a principal-component analysis
(PCA), the blood-derived T cell subsets
were placed along the main principal
component 1 (PC1), in the order Tn-
Tcm-Tem-Temra (Figure 1E), whichmirrors the DNA de-methylation in PMDs. Temra cells fell at
the extreme position along PC1 in relation to Tn cells, suggest-
ing that they are the most differentiated population. However,
their inter-donor pool variation was larger compared to other
cell types (Figure S2D). In contrast to Temra cells, BM-Tmem
cells took an ‘‘intermediate’’ position on PC1 close to circu-
lating Tcm and Tem cells, indicating that their epigenetic
imprint toward terminal differentiation is less pronounced
(Figure 1E).
These data show that DNA de-methylation in heterochromatic
parts of the genome accompanies Tmem cell differentiation in
the order of Tn-Tcm-Tem-Temra with BM-Tmem cells clustering
with the Tcm and Tem cell populations.
Comprehensive Transcriptome Analyses Reveal a
Progressive Change with Tmem Cell Differentiation in
the Order of Tn-Tcm-Tem-Temra
We generated full transcriptomes by RNA-seq and determined
expression profiles for total RNA, mRNAs, miRNAs, lncRNA,
and circRNA for Tn cells and Tmem subsets. Our analysis
identified previously described RNAs, as well as previously un-
known RNAs (including 981 novel miRNAs, 173 lncRNAs, and
4,826 candidate circRNAs) and many differentially expressed
RNAs between the T cell subtypes (Tables S2–S4).
We performed PCA on each of these functionally independent
RNA species. Our analysis revealed a consistent pattern with
respect to the main component PC1: for all RNA species, the cell
types fell along this axis in the strict order of Tn-Tcm-Tem-Temra
(Figure 2A). As observed for DNA-meth, BM-Tmem cells took an
intermediate position close to Tcm and Tem cells from the blood
rather than resembling the most terminally differentiated Temra
cell population. For total RNAand lncRNAs,PC2 indicated proper-
ties of Tn that were recapitulated in Temra cells and distinguished
them from the othermemory subsets. Inter-donor pool differences
were generally small, except in the miRNA datasets, in which one
donor pool became separated by PC2 from all others. Thus, the
consistent arrangement of the T cell subtypes on PC1 for all RNA
species indicated a progressive change of the transcriptome
during Tmem cell differentiation (Tn-Tcm-Tem-Temra).
To validate this further, we performed a co-expression
network analysis using the Tn, Tcm, and Tem samples and
focused on the 700 most variable genes or on transcriptional
regulators (TRs). The topology of both networks showed similar
features, with two major gene clusters and a smaller number of
genes connecting these two clusters (Figure 2B). Overlaying
the expression differences of the included genes revealed
that one major cluster was defined by Tn-, the other by Tem
cell-associated genes. Tcm cell-associated genes mainly con-
nected the two main clusters, indicating that this population
indeed represents an intermediate stage of T cell differentiation.
An additional bioinformatic approach was used to evaluate the
mode of differentiation. We used the degree of similarity of the
entire transcriptomesbetweenTn, Tcm, andTemcells andcalcu-
lated the likelihood of possible differentiation models: two linear
models in the order of Tn-Tcm-Tem or Tn-Tem-Tcm and one
bifurcatedmodel inwhichTcmandTemcells arise independently
from Tn. As shown in Figure 2C, the linear Tn-Tcm-Tem model
had the highest cosine similarity score of 0.98 (max = 1) and
was significantly different from the other two models (p < 1016).
These data show that the transcriptome changes progres-
sively during Tmem cell differentiation in the order of Tn-Tcm-
Tem-Temra.
Chromatin Accessibility and DNA-Meth Analyses
Support a Linear Model of Differentiation for Circulating
Tmem Cells
We wanted to clarify whether the linear relationship between the
Tmem cell subsets (Tn-Tcm-Tem-Temra) apparent from theDNA-meth and transcriptome data (Figures 1E and 2A), could
also be deduced from epigenetic imprints in the chromatin struc-
ture. For this, we first analyzed genome-wide DNA accessibility
maps, which were generated by NOMe-seq. In a PCA, again a
linear arrangement of the blood-derived T cell subsets in the
order of Tn-Tcm-Tem-Temra was visible on the 2nd most impor-
tant component PC2 (Figure 2D). However, the different popula-
tions were generally less stringently separated. The main
component PC1 separated the replicates Hf03 and Hf04 from
Hf06, which reflected a slight change in the NOMe protocol
between these samples (Figure S2E and Supplemental Experi-
mental Procedures). In addition, when we called accessible
( = nucleosome-depleted) regions (NOMe-peaks) from Tn,
Tcm, and Tem cells and compared their degree of accessibility
between the cellular subtypes, the vast majority of sites gained
or lost accessibility in the order Tn-Tcm-Tem (Figure 2E).
Next, we analyzed global DNA-meth profiles (by RRBS) of
blood- and bone-marrow-derived Tmem cell subsets, with the
latter population subdivided into a tissue-resident CD69+ and a
circulating CD69 fraction (CD69 being a regulator of tissue
egress and marker for tissue-resident cells; Sathaliyawala
et al., 2013). While the CD69 fraction clustered closely to Tcm
and Tem cells from the blood, the CD69+ tissue-resident
BM-Tmem subfraction deviated from its CD69 counterpart,
as well as from blood-derived circulating populations in PC2
(Figure 2F), indicating a major epigenetic imprint for their tissue
residency and specialized function.
Taken together, our results from epigenomic and trans-
criptomic analyses support a linear model of differentiation for
circulating Tmem cells from the blood with the bone-marrow-
resident (CD69+) T cell population deviating early and displaying
a specific epigenetic imprint (Figure S2F).
Changes in DNA-Meth of Transcriptional Control
Elements Are Associated with Tmem Cell
Differentiation
DNA-meth can control the expression of genes, which are
required for the maintenance of lineage identity, as found for
Foxp3 in regulatory T cells (Huehn et al., 2009). This holds true
also for CD4+ Tmem cells, as we found a correlation between
DNA-meth andgene-expression changes,whenweusedan inte-
grative sparse linear regression model measuring DNA-meth in
promoters and gene bodies (Figure S2G). While the highest
impact on gene expression was computed for predicted TF bind-
ing in accessible chromatin sites (NOMe peaks around genes),
DNA-meth had a higher regulation potential than miRNAs.
With our genome-wide epigenetic datasets we therefore
strived to (1) elucidate to what extent DNA-meth is involved in
the regulation of known key Tmem cell checkpoint regulators,
and (2) investigate whether epigenomic data could identify novel
transcriptional regulators of Tmem differentiation.
For this, we called differentially methylated regions (DMRs)
from the WGBS datasets, using the Metilene software (J€uhling
et al., 2016) applying strict selection criteria (min. #CpGs = 5;
min. coverage = 5 reads) and a context-sensitive filtering step
to reduce the contribution of the global de-methylation effect
observed in PMDs (‘‘adaptive filtering,’’ Supplemental Experi-
mental Procedures). This approach resulted in 1670 DMRs
between Tn, Tcm and Tem cells (Table S5) associated withImmunity 45, 1148–1161, November 15, 2016 1151
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Figure 2. Progressive Changes in the Transcriptomes and in the DNA Accessibility Profiles Support a Linear Differentiation Model for
Circulating Human CD4+ Tmem Subsets
(A) PCAs of different RNA species for Tn, Tcm, Tem, Temra cells from blood, and Tmem cells from the bone-marrow (BM-Tmem).
(B) Co-regulation network based on the top 700 most variable genes in the dataset (top) or based on transcriptional regulators (TRs, bottom). Nodes represent
genes colored according to the corresponding fold-change to mean expression. Links are unweighted and represent significant correlations.
(C) Three possible differentiation models (x axis) were compared using a designed similarity score (y axis), based on the hypothesis, that T cells that are closer to
each other in the differentiation order should showmore similar gene-expression profiles. The plot shows the distribution of similarity scores obtained (error bars
denote SD estimated from 100.000 bootstrap samples). A significantly higher score was obtained for Tn-Tcm-Tem compared to the other models (bootstrapped
t test p value).
(D) PCA of DNA accessibility data (based on NOMe-seq data).
(E) Visualization of the degree of DNA accessibility (quantile-normalized GCHmethylation levels) in consistent nucleosome depleted regions (NOMe-peaks) with a
statistical difference between at least two cell types. Bars denote mean and SD.
(F) PCA of DNA-meth data (based on RRBS data). CpGs with min. coverage of 5 were considered; only CpGs with calls in all indicated samples were used.970 protein-coding genes. These DMRs seemed functionally
relevant for the regulation of gene expression as most of them
were located within or proximal to genes and were classified
as promoters or enhancers according to their histone modifica-
tion profile (Figure S3A). The majority of these DMRs showed a
continuous (Tn > Tcm > Tem, 47%) or early (Tn > Tcm and1152 Immunity 45, 1148–1161, November 15, 2016Tem, 26%) decrease in DNA-meth with Tmem cell generation
(Figure 3A).
Next, we analyzed the correlation between DNA-meth
changes and gene expression and found that 516 of the DMRs
(36%) displayed an inverse correlation to gene expression (Fig-
ure S3B). Such DMRs showed the paradigm mode of gene
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regulation by DNA-meth, in which transcriptional control ele-
ments, such as promoter and enhancers, are repressed by
increased DNA-meth, whereas a loss of DNA-meth at these ele-
ments leads to gene activation. Other DMRs were associated
with genes by location, which (1) were not expressed in any
cell type, (2) the expression of which did not change, or (3) the
expression change correlated to the methylation change (Fig-
ure S3B). These classes of DMRs might serve different functions
such as (1) preparing a locus for gene expression upon additional
environmental signals or locking a locus to prevent alternative
cellular fates, (2) stabilizing otherwise transient gene expression,
or (3) affecting sites acting as silencers. Furthermore, it cannot
be excluded that some DMRs might also act as long-range reg-
ulators for distant genes.
These data show that in addition to the large-scale DNA de-
methylation in PMDs, transcriptional control elements such as
promoters and enhancers are targets of epigenetic regulation
during Tmem cell differentiation.
Known Regulators of Tmem Differentiation
and Function Display DNA-Meth Changes
in Transcriptional Control Regions
To test the assumption that key factors regulating Tmem differ-
entiation and function are under epigenetic control, we extracted
a list of 144 known memory-related genes according to recent
reviews (Figure S3C) and checked for the occurrence of DMRs
in their loci. One quarter of these Tmem cell-related genes dis-
played one or several DMRs (Figure 3B), 95% of which were
associated with a promoter or enhancer histone signature
(Table S5). The largest group lost DNA-meth with progressive
differentiation, which correlated with an increase in expression
(Figure 3B). Among them were genes upregulated upon differ-
entiation from naive to memory states, including surface or intra-
cellular receptors such as PDCD1 (PD-1), IL2RA, and IL2RB,
NOD2, SLAMF1, and TNFRSF1B, but also many transcriptional
regulators such as RUNX3 (Figure 3C, top), NFATC2, BATF,
MAF, TBX21 (T-BET), the CD45-splicing regulator HNRNPLL,
PRDM1 (BLIMP-1), DUSP4, DUSP5, STAM, TOX, and ZEB2. In
a smaller group, increased methylation was linked with
decreased expression. This group included the signature
markers of Tn and Tcm SELL (L-SELECTIN; Figure 3C, middle)
and CCR7, but also several key transcriptional regulators,
namely TCF7 (encodes TCF-1; Figure 3C, bottom), LEF1, and
BACH2, which are known to control the development or mainte-
nance of Tmem cells. In a few genes (FOXO1 and BACH2), loss
of DNA-meth was associated with a decrease in expression;
accordingly, these DMRs might control transcriptional silencers.
In other cases (NOTCH1, SLFN12L, RPTOR, ZBTB32, RBPJ),
a change in methylation was not correlated to changes in
expression. It is of high interest to investigate whether loss of
DNA-meth in genes of this group is not a requirement for expres-Figure 3. Epigenetic Changes in Known Tmem Cell-Related Genes
(A) Patterns of DNA-meth changes in differentially methylated regions (DMRs
cnt., continuous; inter., intermediate; decr., decrease; incr., increase. Bars deno
(B) List of known Tmem cell-related genes (based on Figure S3C) which display
(C) Examples of DMR-containing Tmem regulator genes (RUNX3, top; SELL, midd
track). The following tracks are shown in each panel (top to bottom, each for Tn
genome segmentation by EpicCSeg (color legend shown on the bottom).
1154 Immunity 45, 1148–1161, November 15, 2016sion but might act by stabilizing transcription, as was found
previously for the TSDR (CNS2) enhancer region in the FOXP3
locus (Huehn et al., 2009; Polansky et al., 2008).
While a causal role of DNA-meth in the regulation of these
genes remains to be experimentally demonstrated, these find-
ings provide evidence that epigenetic mechanisms contribute
to the developmental regulation of Tmem cells by controlling
the expression of key genes.
Integrative Analyses of Epigenomic and Transcriptomic
Datasets Facilitate the Identification of Functional
Regulator Candidates for Tmem Differentiation
In addition to screening for known developmental regulators,
a reciprocal approach can be applied, in which the occurrence
of DMRs is used to identify novel candidate genes that might
be involved in the control of Tmem differentiation and which un-
dergo direct epigenetic expression control. To this end, 171
DMRs associated with 104 transcriptional regulator genes
were identified (Table S5), indicating that these genes might
contribute to memory development and maintenance. This list
included the gene FOXP1.
While these candidates seem to undergo direct expression
control by DNA-meth, a different class of regulators might gain
or lose functional importance for Tmem cell development and/
or function because their binding sites in target genes are being
exposed (or blocked) by chromatin remodeling. To identify such
‘‘functional epigenetic’’ regulators, we used an alternative
approach combining DNA accessibility data and transcriptomic
data. In this, the impact of a given TF on the transcriptional profile
is determined by the accessibility of its binding sites within pro-
moters and enhancers in its target genes. We used our DNA
accessibility dataset (NOMe-seq data) and computed TF binding
affinities to open chromatin regions (NOMe-peaks). Using a
machine learning approach (Schmidt et al., 2016), we modeled
differential gene expression between T cell subsets based on
these TF binding predictions. In this, the impact of each TF to
the differential transcriptional profile is calculated and TFs with
a strong influence can be extracted. Indeed, comparison of
modeled to observed gene-expression changes, as measured
by RNA-seq, displayed a high accuracy (Figure S4A) supporting
the validity of the approach. A number of regulatory TF candi-
dates for Tn cells and Tmem subsets could be extracted (Fig-
ure 4A and 4B). The lists comprised TFs known to control
Tmem cells, such as BCL6, E2F2, and RUNX3, as well as new
candidates, including AHR, CREB1, ETS1, FLI1, FOXP1,
FOXJ3, NFEL2, NRF1, RFX3, and ZFP161. For a number of these
(e.g., AHR, FLI1, FOXP1, and RUNX3), we also found an associ-
ated DMR in their genes and differential expression during Tmem
cell differentiation (Table S5), indicating that these factors not
only drive transcriptional profiles during Tmem differentiation
but are under epigenetic regulation themselves.). DMRs changing in the order Tn-Tcm-Tem are shown in the upper row.
te mean and SD.
at least one DMR in their loci (color legend shown on the bottom).
le; TCF7/TCF-1, bottom) showing the location of the identified DMRs (red, top
, Tcm, Tem): Gene annotation from RefSeq; DNA-meth (WGBS); polyA-RNA;
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Figure 4. Selection of Tmem Cell Regulator Candidates Based on Their Predicted Binding Affinities in Open Chromatin Regions of Differen-
tially Expressed Genes
(A) Bar plots showing normalized feature values (y axis) for each TF (x axis) computed using amachine learning approach (based on logistic regression classifiers)
to predict differentially expressed genes in pairwise comparisons of two cellular subtypes. Differences in predicted TF affinities, calculated from open chromatin
regions (NOMe-peaks) in the vicinity of a gene, were used as features in the classification. Large feature values denote a higher impact of the TF on differential
gene expression.
(B) Summarized representation of all selected TFs shown in (A). Filled boxes reflect that a TF (column) has been selected as a feature in the respective comparison
(row). TFs joint by double colons indicate that both TFs are predicted to bind as a complex. The TF FOXP1 is highlighted in gray.With these analyses we identified several promising new TFs
from epigenomic data which are likely to be involved in Tmem
cell generation and function.
FOXP1 Is an Epigenetically Controlled ‘‘Naive-Keeping’’
Checkpoint Regulator
We found the TF FOXP1 to be a particularly interesting candidate
for Tmem cell regulation due to several reasons: First, a DMR in
the FOXP1 locus displayed increasing DNA-meth, concomitantwith decreased mRNA levels from Tn to Tem (Table S5); second,
FOXP1 was predicted to bind to accessible chromatin regions
and thus contribute to differential gene expression in Tn versus
Tem (Figure 4); and third, FOXP1 was among the top predicted
Tn cell-specific regulators according to an iRegulon (Janky
et al., 2014) analysis (Figure S4B), which is based on the enrich-
ment of TF binding sites in genes contributing to the cell-type-
specific clusters shown in Figure 2B. Therefore, we selected
the TF FOXP1 for a more detailed investigation.Immunity 45, 1148–1161, November 15, 2016 1155
Ourdatasuggested thatFOXP1might actasan important regu-
lator for theTn-to-Tmem transition.Confirming this,we found that
T cell-specific depletion of Foxp1 protein expression in Foxp1
conditional-deficient mice resulted in loss of the naive CD44low
phenotype inTcells (Figure 5A). Thesefindings togetherwithpub-
lished data (Feng et al., 2011; Wei et al., 2016), support the view
that Foxp1 acts as a ‘‘naive-keeping’’ factor for T cells. Analyses
of DNA-meth in our datasets revealed a DMR in the FOXP1 locus,
which displayed a strong progressive gain of methylation with
differentiation (Tn < Tcm < Tem), which was classified as a selec-
tive active promoter in Tn cells (Figure 5B) based on the displayed
histone modification patterns (by EpiCSeg, Mammana and
Chung, 2015). Indeed, a methylation-sensitive promoter activity
of the FOXP1-DMR was confirmed in luciferase reporter gene
assays in primary human CD4+ T cells, as the FOXP1-DMR was
able to drive luciferase expression when cloned upstream of the
reporter gene in the sense orientation, but not when the orienta-
tion of the FOXP1-DMR was inverted or when the FOXP1-DMR
was methylated (Figure 5C).
Consistent with the occurrence of a Tn cell-specific promoter,
we found the FOXP1 protein expression in humanCD4+ T cells to
be highest in Tn cells and to be decreased in Tcm, Tem, and
Temra cells (Figure 5D). In addition, we found indications in our
RNA-seq datasets for three alternative shorter RNA isoforms,
which started within or directly downstream of the FOXP1-
DMR promoter (Figure S4C). All three isoforms showed preferen-
tial expression in Tn compared to Tcm and Tem cells as
measured by qPCR (Figure 5E). In addition, two of them contain
the complete protein coding sequence (Figure 5E), which we
verified by single molecule real-time sequencing (data not
shown).
Taken together, these results validate FOXP1 as an important
gate-keeper for the naive-to-memory transition, which was iden-
tified by integrative analyses of epigenomic data. In addition,
these analyses also enabled the identification of the epigenetic
control mechanisms regulating differential FOXP1 expression
during Tmem cell generation.
DISCUSSION
This study reveals that the differentiation of Tn cells into distinct
types of memory cells and their long-term maintenance is con-
nected to major epigenetic and transcriptional reprogramming.
This is manifested on a global scale with a genome-wide
segmented loss of DNA-meth during differentiation and in
gene-specific epigenetic changes, which control the stage-spe-
cific expression and/or function of transcriptional regulators.
As our first major finding, we documented a progressive
genome-wide loss of DNA-meth upon transition from the naive
to the memory stages. This de-methylation was most prominent
in ‘‘partially methylated domains’’ (PMDs, Hon et al., 2012; Lister
et al., 2009), a feature shared in memory differentiation of B cells,
but absent during the differentiation of monocytes into macro-
phages (Wallner et al., 2016). PMDs have been associated with
heterochromatic histone signatures and correlate to regions,
which are replicated late during S phase and progressively
lose methylation during strong proliferation (Aran et al., 2011).
Consistent with this, T and B cells, but not monocytes, undergo
extensive proliferation during differentiation as a result of TCR-1156 Immunity 45, 1148–1161, November 15, 2016(BCR-) mediated activation. It is therefore feasible that the
observed PMD-associated loss of methylation is a consequence
and a signature of highly proliferative episodes in the history of
these cells.
This interpretation is supported for CD4+ Tmem cells by two
additional observations in our study: (1) the progressive short-
ening of telomere length in the order of Tn-Tcm-Tem (Fig-
ure S5A), and (2) the progressive loss of methylation in PMDs
observed in short-term culture of Tn cells proliferating in vitro
after TCR-mediated activation (Figures S5B and S5C). It remains
to be investigated whether the global de-methylation is just a
tolerated bystander effect of proliferation or whether it consti-
tutes a telomere-independent senescence signal for the cell as
suggested by studies on hematopoietic stem cells under prolif-
erative stress (Beerman et al., 2013).
These findings are relevant for the interpretation and functional
assignment of DNA-meth changes found by gene-specific
DNA-meth assays. Using the epigenomic maps of this study as
a reference, gene-specific differentially methylated regions
(DMRs), which might have (direct) functional relevance for gene
expression, can be discriminated from DMRs in regions that
are likely to represent a mere imprint from the proliferation his-
tory. This discrimination could be of particular relevance when
studying epigenetic changes in T cells isolated from chronic
stimulatory conditions, e.g., inflammatory diseases such as
rheumatoid arthritis or lupus erythematosus where disease-
associated methylation differences have been reported (de
Andres et al., 2015; Javierre et al., 2010).
The second major conclusion from our global epigenomic an-
alyses sheds light onto the still-controversial subject of themode
of memory differentiation of human CD4+ T cells: Do memory
cells originate (1) early after antigen encounter independently
of (but in parallel to) themassive expansion of short-lived effector
cells (parallel or bifurcative differentiation model, Arsenio et al.,
2015) or (2) do they develop from effector cells, which adopt
Tmem stages toward the end of the primary effector phase
(linear model)? While we could not directly address the posi-
tioning of effector cells in relation to memory development with
the present dataset, all our findings are more consistent with
the linear progression model for circulating Tmem cells: We
observed a strong loss of DNA-meth in PMDs upon transition
from Tn to Tcm cells, which was further reduced in the more
differentiated Tem and Temra phenotypes. These data indicate
that Tcm cells would have already passed through a phase of
intense proliferation during initial activation and prior to convert-
ing into resting memory cells. While the parallel model cannot be
formally excluded by this, additional proliferation-independent
datasets were similarly more consistent with the linear model,
including: (1) patterns of DNA-meth at single-DMR resolution,
as well as patterns of DNA accessibility (NOMe-peaks), showed
almost exclusively changes in the order of Tn-Tcm-Tem, (2)
changes in the transcriptomes grouped the samples along a pro-
gressive Tn-Tcm-Tem-Temra cell differentiation axis, (3) network
analysis of co-expressed genes placed the Tcm phenotype as
intermediate to the Tn- and Tem-associated clusters, and (4)
calculation of the similarity of the transcriptomic profiles re-
vealed the linear Tn-Tcm-Tem model as the most likely one.
These conclusions are in part in contrast to conclusions from
restricted expression analyses of murine CD8+ single cells
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Figure 5. ANewly IdentifiedMethylation-Sensitive Promoter Drives Alternative CodingmRNA Isoformsof the ‘‘Naive-Keeping’’ Transcription
Factor FOXP1 in Tn
(A) CD4+ T cells isolated from spleens of Foxp1+/flox CD4 Cre and Foxp1flox/flox CD4 Cre mice at the age of 6–10 weeks were analyzed by flow cytometry for a
CD44high memory phenotype. Dot plots show CD62L and CD44 surface expression after gating on CD4+ living cells.
(B) Genomic view of the human FOXP1 locus indicating a distinct FOXP1-DMR (red box) gaining DNA-meth from Tn to Tcm to Tem cells. The following tracks are
shown (each for Tn, Tcm, and Tem cells): RefSeq annotation, DNA-meth (WGBS), 6 histone modifications, total RNA coverage and segmentation by EpiCSeg
(red, promoter; green, enhancer; light blue, transcribed; dark blue, repressed).
(C) Luciferase reporter assay testing amethylation-sensitive and orientation-dependent promoter activity of the FOXP1-DMR in primary human CD4+ T cells. The
Firefly luciferase signal was normalized to the signal of the Renilla transfection control and is shown relative to the empty vector control. One representative
experiment performed in triplicates out of two independent experiments is shown.
(D) FOXP1 protein expression in gated human Tn, Tcm, Tem, and Temra cells as assessed by intracellular staining and flow cytometry. Numbers: geometricmean
of the FOXP1 signal. Control staining (contr.) was done using the fluorescently labeled secondary antibody only.
(E) Schematic depiction of different human FOXP1 RNA isoforms. The position of the FOXP1-DMR is shown and the protein coding exons are indicated as boxes.
Three isoforms start within or shortly downstream of the FOXP1-DMR. Their relative expression values are shown for the different cell types (normalized to Tn
cells) measured by qPCR using the indicated primers (arrowheads). One representative experiment performed in technical triplicates (mean and SD) out of two
independent experiments is shown.
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(Arsenio et al., 2015). However, elegant in vivo approaches using
adoptive transfer systems of single murine CD8+ memory cells
(Gerlach et al., 2013a; Graef et al., 2014) also argue in favor of
a linear differentiation model. As similar experiments have not
been conducted for CD4+ cells yet and are impossible in the
human system, our data represent new insights into this topic.
The distinct positioning of Temra cells in the analysis of
genome-wide DNA-meth and transcriptomic data suggests that
they represent a late stage of Tmem differentiation and have un-
dergone extensive proliferation. Alternatively, circulating Temra
cells might represent survivors of prolonged effector proliferation
due to chronic re-activation. This could also explain the
enhanced heterogeneity of the Temra samples, since their epige-
netic imprint might have been specialized over time. Indeed,
increased frequencies of Temra cells have e.g., been reported
in response to persistent CMV infection (Derhovanessian et al.,
2011) and in liver disease, where high Temra cell numbers repre-
sent a significant risk of organ rejection after organ transplanta-
tion (Gerlach et al., 2013b). In contrast, Tmem cells isolated
from the bone marrow did not display a Temra-like epigenetic
phenotype but were positioned between Tcm and Tem cells,
indicating that they have preserved significant expansion and
differentiation capacity. In addition, the CD69+ tissue-resident
subset of BM-Tmem cells displayed a distinct DNA-meth profile,
indicating that acquisition of a resident phenotype, too, is linked
to significant epigenetic reprogramming.
The third pillar of our study is dedicated to the identification of
factors, which drive and/or maintain Tmem cells. In this
endeavor, we identified many non-coding RNAs (ncRNAs),
which are highly and/or differentially expressed in Tn and
Tmem cells. Among them, we identified numerous circRNAs
for which the normal linear host transcript is barely detectable
(Rybak-Wolf et al., 2015), thus, activity of these genes would
have been missed in standard polyA- selected RNA-seq and/
or normal linear splice analysis. These and other ncRNA mole-
cules (lncRNAs, miRNAs) may not only reflect but also induce
functional consequences during Tmem differentiation. The
expression of the ncRNAs appears to be coordinated and finely
tuned during Tmem differentiation with a remarkable link to other
epigenomic changes. Therefore, our dataset provides a deep
basis to further investigate the direct contribution of ncRNAs to
Tmem differentiation and to clarify the mutual regulatory impact
between ncRNAs and chromatin structure.
In addition to RNAs, we report two classes of protein regula-
tors, which include known and potentially new factors controlling
Tmem cell generation and function: (1) TFs, which undergo
epigenetic expression control during Tmem cell formation, and
(2) TFs, which gain or lose functional importance as their binding
sites in target genes are being exposed or closed, respectively,
independently of their own expression change. For the first
class, we found several widely discussed regulators of Tmem
differentiation, which displayed differential DNA-meth in pro-
moter or enhancer regions that anti-correlated with differences
in gene expression levels, following the classical paradigm of
methylation-controlled gene repression. For several of them
(e.g., IL2RA, RUNX3, NFATC2, MAF, BACH2, FOXO1), epige-
netic control in Tmem differentiation has not been reported so
far and awaits experimental confirmation. Interestingly, among
differentially methylated genes was also HNRNPLL, involved in1158 Immunity 45, 1148–1161, November 15, 2016alternative splicing of CD45 to the Tmem signature isoform
CD45RO, and the two homing-related receptors, SELL (L-selec-
tin) and CCR7, suggesting that the permanent change in the
recirculation pattern with transition from Tcm to Tem is epigenet-
ically fixed. For others, concordant epigenetic changes have
already been described in murine CD8+ T cells (e.g., BATF,
LEF1, PDCD1, TBX21, TCF7, ZBTB32; Scharer et al., 2013;
Youngblood et al., 2011; Hashimoto et al., 2013).
As for the second class of TFs, we identified FOXP1 as one of
the top candidates, a less well known but functionally confirmed
Tmem regulator in mice (Feng et al., 2011; Wei et al., 2016). Our
present analyses support a similar function in human CD4+
Tmem and additionally unravel the epigenetic control of the
FOXP1 gene. Other prime TF candidates include TFs previously
implicated in Tmem regulation such as RUNX3, E2F2, LEF1,
BCL6, or members of the ELF-, KLF-, or FOXJ- families, as
well as CREB1, ETS-1, and JUN-FOS, which are known to be
involved in multiple cellular processes of differentiation and
activation. Additional interesting candidates include (1) the aryl
hydrocarbon receptor, AHR, which has been implicated in differ-
entiation of CD4+ T cells into pro- or anti-inflammatory subsets
and, hence, to modulate autoimmune diseases in various animal
models (reviewed in Esser et al., 2009; Hanieh, 2014) and (2) the
ets-family member FLI-1, which has been reported to affect
thymic T cell development, TCR signaling, glycosphingolipid
metabolism, and cytokine expression and has been implicated
in autoimmune diseases, too (Richard et al., 2013; Sato et al.,
2014). Others of the top-predicted TFs have not been directly
associated to regulation of Tmem differentiation yet, but are
players in potentially relevant cellular processes, such as intra-
cellular signaling (RFX3, via the RAS-MAPK pathway), metabolic
processes (NRF1 and SREBF1, associated with mTORC1
signaling), and chromatin remodeling (ZFP161, targeting of the
repressive Polycomp complex). Thus, important Tmem cell
properties might be under the control of yet neglected transcrip-
tional regulators that could be revealed by the integrated anal-
ysis of transcriptomic and epigenomic features.
In conclusion, the comprehensive epigenomic analysis of
several human CD4+ Tmem subsets in this study revealed in-
sights into the Tmem differentiation pathway and allowed the
identification of relevant epigenetically controlled transcriptional
regulators. In addition, these data constitute a resource of
normal T cell differentiation, which can serve as a reference for
the identification of altered epigenetic signatures in T cells
from pathological situations such as chronic inflammatory dis-
ease. The challenging task for the future will be the application
of ‘‘epigenetic engineering’’ to achieve therapeutic re-program-
ming of pathogenic T cells or to optimize T cells for their use in
cellular therapy.EXPERIMENTAL PROCEDURES
T Cell Isolation
PBMCs from blood of healthy female donors or from bone marrow samples of
female donors undergoing hip replacements were isolated and enriched for
CD4+ T cells using the MACS-technology (Miltenyi Biotech). Tn cells and
Tmem subsets were purified by flow cytometry using markers shown in Fig-
ure S1A. Donors gave their written and informed consent prior to participating
in the study (Ethics committee of the Charite Universitaetsmedizin Berlin,
application numbers EA1/116/13 and EA1/105/09).
Epigenomic Data Generation
WGBS was carried out by the combined analysis of two bisulfite-converted
libraries using the pre-bisulfite library protocol (Urich et al., 2015) and the
TruSeq DNA Methylation kit (Illumina, San Diego, USA). RRBS libraries were
prepared as previously published (Boyle et al., 2012). For NOMe-seq, nuclei
of fixed cells were extracted and DNA-meth on GpCmotifs in accessible chro-
matin regions was introduced using the M. CviPI methyltransferase, followed
by WGBS analysis. ChIP-seq for histone modifications was carried out as
previously described (Arrigoni et al., 2016; Kinkley et al., 2016). RNA was ex-
tracted using the miRNeasy Micro Kit (QIAGEN) and three Illumina sequencing
libraries were prepared (small RNA sequencing library, one stranded total
RNA, and one stranded mRNA library). Sequencing was carried out on HiSeq
2000 and HiSeq2500 machines (Illumina). Bioinformatical processing of the
sequencing reads includingmapping to the hg19 reference genome is outlined
in the Supplemental Experimental Procedures section.
DNA Methylation Analyses
Genome segmentation based on WGBS data was performed using
MethylSeekR (Burger et al., 2013). The methylation levels from both strands
were aggregated and weighted average methylation levels were plotted.
WGBS data from B cells (Blueprint consortium) was converted to hg19
coordinates using the liftOver tool (Rosenbloom et al., 2015) and segmentation
was carried out. Differentially methylated regions (DMRs) were predicted
with Metilene (J€uhling et al., 2016) in de-novo mode among sites with at least
53 coverage.
Calling of Accessible Chromatin Region
Nucleosome-depleted regions (NOMe-peaks) were identified by segmenting
the GCH-methylation signal with a binomial hidden Markov model with two
states (1 open/NDR, 0 background) in each sample separately and consistent
NOMe-peaks confirmed in all three replicates were selected.
Identification of mRNAs, miRNAs, lncRNAs, and circRNAs
Expression values for total RNA were quantified using TopHat, Htseq-count,
and DESeq2 (Anders and Huber, 2010). Cufflinks (Trapnell et al., 2010) was
used for the identification of novel lncRNAs. To remove possible coding genes,
we estimated the coding potential of novel transcripts using PhyloCSF (Lin
et al., 2011) and CPAT (Wang et al., 2013). Mature miRNA read counts
were estimated for each sample using miRDeep2 (Friedl€ander et al., 2012)
and miRBase (version 21) annotations. CircRNAs were detected, filtered,
and annotated as described before (Memczak et al., 2013).
Co-Expression Network Construction
Expression data of Tn, Tcm, and Tem cells (3 replicates each) was filtered
using either a list of human transcriptional regulators (TRs) or the 700 most
variable genes (i.e., most significant p values in an ANOVA-based analysis)
to get a reduced expression table of present genes. The group of TRs
contained transcription factors (TFs), co-factors, RNA-binding proteins and
chromatin remodelers originating from the TFCat data base (Fulton et al.,
2009). The expression matrices were loaded into BioLayout Express3D
(Theocharidis et al., 2009) and co-regulation networks were generated
with a Pearson correlation cutoff of 0.9. The predicted gene-gene pairs were
visualized by Cytoscape (Shannon et al., 2003) and fold change expression
values calculated against the group mean were mapped to the network.
Prediction of Transcriptional Regulators Using a Machine-Learning
Approach to Model Differential Gene Expression
Weused amachine-learning approach based on a logistic regression classifier
with the elastic net penalty (Zou and Hastie, 2005) to model differential gene
expression between the Tn, Tcm, and Tem subsets. Because the TF features
for the logistic regression classifier, we used the ratio of TF gene scores, which
were computed using TEPIC (Schmidt et al., 2016). TFs predicted to contribute
to differential gene expression were selected.
Functional Analyses on the TF FOXP1 and the FOXP1-DMR
For the generation of a T cell-specific Foxp1 deletion, a conditional Foxp1
knock-out allelewasgeneratedusingstandardgene targeting techniques inmu-
rine ESCs by introducing loxP sites into intronic regions flanking exons 10–12(T. Patzelt, O. Gorka, and J. Ruland, manuscript in preparation). The generated
Foxp1-floxed mice were crossed to CD4-Cre animals (Lee et al., 2001).
Intracellular staining of FOXP1 protein in human CD4+ T cells was performed
using the Fixation/Permeabilization Buffer set for intracellular Foxp3 staining
(eBioscience) in a two-step staining procedure (primary FOXP1 antibody
polyclonal #2005, Cell Signaling Technology, DyeLight-649-labeled donkey
anti-rabbit secondary antibody #406406, BioLegend). Samples were acquired
on a BD LSRFortessa instrument (BDBioscience).
The FOXP1-DMR was cloned into the CpG-free Firefly luciferase vector
pCpGL (Klug and Rehli, 2006). Treatment with the M.SssI CpGmethyltransfer-
ase (NEB) allowed selective methylation of the FOXP1-DMR. Ex vivo isolated
CD4+ T cells were TCR-stimulated for 48 hr and transfected with the FOXP1-
DMR Firefly vector and a pRL-TK Renilla control vector (Promega) using the
Neon Transfection System (Life Technologies). Firefly and Renilla luciferase
activity were assessed using the Dual Luciferase Assay Kit (Promega) after
24 hr. The Firefly luciferase signal was normalized to the Renilla reporter signal.
Expression levels of the FOXP1RNA isoformswere quantified using the plat-
inum SYBR green qPCR superMix-UDG (Thermo Fisher Scientific) on a Step
One instrument (Thermo Fisher Scientific). Relative transcript levels were
normalized to hRPS18. Primer sequences are given in the Supplemental
Experimental Procedures section.
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